KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 81 filers reported holding KEROS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,014 | -5.9% | 299,000 | 0.0% | 0.14% | -24.6% |
| Q1 2023 | $12,767 | -11.1% | 299,000 | 0.0% | 0.19% | -11.2% |
| Q4 2022 | $14,358 | -99.9% | 299,000 | 0.0% | 0.22% | +39.6% |
| Q3 2022 | $11,248,000 | +36.2% | 299,000 | 0.0% | 0.15% | +40.0% |
| Q2 2022 | $8,261,000 | -52.5% | 299,000 | -6.6% | 0.11% | -40.2% |
| Q1 2022 | $17,402,000 | -7.1% | 320,000 | 0.0% | 0.18% | -9.4% |
| Q4 2021 | $18,723,000 | +52.1% | 320,000 | +2.8% | 0.20% | +44.0% |
| Q3 2021 | $12,309,000 | -9.4% | 311,135 | -2.8% | 0.14% | -9.0% |
| Q2 2021 | $13,590,000 | -31.0% | 320,000 | 0.0% | 0.16% | -32.0% |
| Q1 2021 | $19,696,000 | -6.6% | 320,000 | 0.0% | 0.23% | -20.6% |
| Q4 2020 | $21,090,000 | – | 320,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 396,911 | $21,584,000 | 5.10% |
| Deep Track Capital, LP | 1,380,306 | $75,061,000 | 4.81% |
| Opaleye Management Inc. | 265,750 | $14,451,000 | 4.49% |
| Octagon Capital Advisors LP | 340,214 | $18,501,000 | 4.00% |
| First Light Asset Management, LLC | 658,145 | $35,790,000 | 3.16% |
| Altium Capital Management LP | 126,000 | $6,852,000 | 2.29% |
| Nantahala Capital Management | 816,830 | $44,419,000 | 1.96% |
| Orbimed Advisors | 1,679,417 | $91,327,000 | 1.48% |
| CHI Advisors LLC | 62,229 | $3,384,000 | 1.44% |
| Parkman Healthcare Partners LLC | 72,690 | $3,953,000 | 1.16% |